Standout Papers

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection 2009 2026 2014 2020 760
  1. Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection (2009)
    Christophe Hézode, Nicole Forestier et al. New England Journal of Medicine
  2. ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis (2014)
    Fred Poordad, Christophe Hézode et al. New England Journal of Medicine
  3. Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3 (2014)
    Stefan Zeuzem, Geoffrey Dusheiko et al. New England Journal of Medicine

Immediate Impact

13 by Nobel laureates 9 from Science/Nature 88 standout
Sub-graph 1 of 14

Citing Papers

A genomic region associated with protection against severe COVID-19 is inherited from Neandertals
2021 StandoutNobel
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
2 intermediate papers

Works of Christophe Hézode being referenced

Ideal oral combinations to eradicate HCV: The role of ribavirin
2015
IL28B polymorphisms and chronic hepatitis C
2010

Author Peers

Author Last Decade Papers Cites
Christophe Hézode 7826 7151 1551 175 8.7k
Marc Bourlière 7391 6796 1303 299 8.5k
Paul J. Pockros 6382 6059 1041 185 8.3k
Marion G. Peters 6837 6772 1366 209 9.6k
Sugantha Govindarajan 7791 6573 2007 181 10.3k
Vinod K. Rustgi 11649 10380 1563 165 13.4k
Tarik Asselah 9060 9046 1244 284 11.7k
Fred Poordad 11602 10559 2280 175 13.0k
Marc G. Ghany 11694 12049 1444 183 14.7k
Robert Flisiak 5207 5252 1461 350 7.6k
George Marinos 6836 6046 914 61 7.8k

All Works

Loading papers...

Rankless by CCL
2026